Adline Chem Lab Limited has informed BSE that the Board of Directors of the Company has considered and approved Unaudited Standalone Financial Results for the quarter ended June 30, 2025.
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
The Board of Directors of Adline Chem Lab Ltd met on August 12, 2025 and approved the Unaudited Standalone Financial Results for the quarter ended June 30, 2025, prepared under Ind AS. The results were recommended by the Audit Committee and reviewed by statutory auditors Jain Kedia & Sharma, whose Limited Review Report contains no qualifications or modifications. The Board also took note of a SEBI circular (dated July 2, 2025) providing a special window for re-lodgement of physical share transfer requests, and instructed management to take necessary steps. The company was formerly known as Kamron Laboratories Limited.
Routine quarterly results filing with a clean (unqualified) auditor review — no red flags for shareholders. The SEBI physical share re-lodgement note is administrative and relevant only for shareholders holding shares in paper form.